Statement: All cancer stages are accepted for the primary trial.
Primary_evidence: Inclusion Criteria:   New diagnosis of breast cancer   New diagnosis if a previous breast cancer patient with negative surgical margins   Patients willing to sign a written informed consent form Exclusion Criteria:   High risk benign lesions as the primary pathology diagnosis